Minimed Group, Inc. (MMED)

Minimed Group Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Oct 24, 2025	Apr 25, 2025	Apr 26, 2024	Apr 28, 2023
Cash & Equivalents	8	11	54	58
Cash & Short-Term Investments	8	11	54	58
Cash Growth	-86.21%	-79.63%	-6.90%	-
Accounts Receivable	588	570	507	430
Other Receivables	-	-	1	1
Receivables	588	570	508	431
Inventory	361	311	292	298
Other Current Assets	34	47	41	57
Total Current Assets	991	939	895	844
Property, Plant & Equipment	818	772	684	618
Long-Term Investments	74	75	76	80
Goodwill	2,256	2,255	2,255	2,255
Other Intangible Assets	119	132	161	194
Other Long-Term Assets	31	28	23	29
Total Assets	4,289	4,201	4,094	4,020
Accounts Payable	242	205	190	213
Accrued Expenses	258	297	281	253
Current Portion of Leases	11	11	8	7
Current Unearned Revenue	11	11	11	19
Other Current Liabilities	38	186	28	27
Total Current Liabilities	560	710	518	519
Long-Term Leases	52	56	41	23
Long-Term Unearned Revenue	4	3	6	4
Long-Term Deferred Tax Liabilities	-	4	4	4
Other Long-Term Liabilities	113	98	77	68
Total Liabilities	729	871	646	618
Common Stock	3,551	3,328	3,464	3,411
Comprehensive Income & Other	9	2	-16	-9
Shareholders' Equity	3,560	3,330	3,448	3,402
Total Liabilities & Equity	4,289	4,201	4,094	4,020
Total Debt	63	67	49	30
Net Cash (Debt)	-55	-56	5	28
Net Cash Growth	-	-	-82.14%	-
Working Capital	431	229	377	325
Tangible Book Value	1,185	943	1,032	953
Land	-	7	7	7
Buildings	-	233	214	213
Machinery	-	395	342	339
Construction In Progress	-	286	294	252

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q